Funder
Japan Agency for Medical Research and Development Department of Industrial Academic Collaboration
Japan Society for the Promotion of Science
BIKEN Foundation
Reference53 articles.
1. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D;Abbink;J. Virol.,2007
2. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport;Babiss;Mol. Cell. Biol.,1985
3. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations;Barouch;Vaccine,2011
4. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;Buchbinder;Lancet (london, England),2008
5. A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques;Capone;J. Virol.,2006